Life Science REIT Balance Sheet Health
Financial Health criteria checks 2/6
Life Science REIT has a total shareholder equity of £267.2M and total debt of £118.1M, which brings its debt-to-equity ratio to 44.2%. Its total assets and total liabilities are £402.4M and £135.1M respectively. Life Science REIT's EBIT is £9.4M making its interest coverage ratio 1.5. It has cash and short-term investments of £13.5M.
Key information
44.2%
Debt to equity ratio
UK£118.07m
Debt
| Interest coverage ratio | 1.5x |
| Cash | UK£13.53m |
| Equity | UK£267.23m |
| Total liabilities | UK£135.13m |
| Total assets | UK£402.36m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LABSL's short term assets (£16.2M) exceed its short term liabilities (£13.5M).
Long Term Liabilities: LABSL's short term assets (£16.2M) do not cover its long term liabilities (£121.6M).
Debt to Equity History and Analysis
Debt Level: LABSL's net debt to equity ratio (39.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if LABSL's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LABSL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LABSL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.